Butterfly Network Inc

Healthcare US BFLY

2.365USD
0.07(2.83%)

Last update at 2025-06-16T14:51:00Z

Day Range

2.312.38
LowHigh

52 Week Range

0.673.78
LowHigh

Fundamentals

  • Previous Close 2.30
  • Market Cap703.10M
  • Volume601704
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-97.09800M
  • Revenue TTM76.22M
  • Revenue Per Share TTM0.35
  • Gross Profit TTM 39.46M
  • Diluted EPS TTM-0.47

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -168.68100M -32.28800M -162.70600M -99.69700M -
Minority interest - - - - -
Net income -168.72300M -32.40900M -162.74500M -99.60100M -
Selling general administrative 83.47M 85.72M 24.39M 18.18M -
Selling and marketing expenses 59.89M 49.60M 26.26M 14.28M -
Gross profit 39.46M 17.05M -61.22300M -20.89500M -
Reconciled depreciation 5.93M 2.09M 1.32M 0.76M -
Ebit -193.02000M -192.72800M -161.61900M -102.29600M -53.08600M
Ebitda -183.60300M -190.64200M -161.56500M -98.93900M -
Depreciation and amortization 9.42M 2.09M 0.05M 3.36M -
Non operating income net other 24.34M 161.09M - - -
Operating income -193.02000M -192.72800M -161.61900M -102.29600M -
Other operating expenses 266.41M 255.29M 207.87M 129.88M -
Interest expense 0.00200M 0.65M 1.14M 0.00000M 0.00000M
Tax provision 0.04M 0.12M 0.04M 0.00000M -
Interest income 3.38M 2.57M 0.28M 2.69M -
Net interest income 3.38M 1.92M -0.85600M 2.69M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.04M 0.12M 0.04M -0.09600M -
Total revenue 73.39M 62.56M 46.25M 27.58M -
Total operating expenses 232.48M 209.78M 100.40M 81.40M -
Cost of revenue 33.93M 45.51M 107.47M 48.48M -
Total other income expense net 24.34M 160.44M -1.08700M 2.60M -
Discontinued operations - - - - -
Net income from continuing ops -168.72300M -32.40900M -162.74500M -99.69700M -
Net income applicable to common shares -168.72300M -32.40900M -144.22337M -99.69700M -50.76500M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 304.27M 417.57M 571.97M 147.19M -
Intangible assets 10.32M - - - -
Earning assets - - - - -
Other current assets 10.39M 9.49M 40.88M 5.57M 7.54M
Total liab 84.22M 92.21M 124.27M 509.12M -
Total stockholder equity 220.05M 325.36M 447.69M -361.93100M -
Deferred long term liab - - - - -
Other current liab 20.17M 26.34M 29.57M 2.07M 5.82M
Common stock 0.02M 0.02M 0.02M 0.00100M 0.00100M
Capital stock 0.02M 0.02M 0.02M 0.00100M -
Retained earnings -729.63800M -595.93800M -427.21500M -394.80600M -232.06100M
Other liab - 10.91M 46.76M 406.85M 1.15M
Good will - - - - -
Other assets - 7.54M 21.27M 414.33M 50.56M
Cash 134.44M 162.56M 422.84M 60.21M -
Cash and equivalents - - - - -
Total current liabilities 44.27M 51.33M 49.83M 69.69M 15.32M
Current deferred revenue 15.62M 15.86M 13.07M 8.44M -
Net debt -109.41000M -130.66900M -395.15100M -6.31200M -
Short term debt 2.19M 1.93M 1.39M 42.78M -
Short long term debt - - - - -
Short long term debt total 25.03M 31.89M 27.69M 53.89M -
Other stockholder equity 949.67M 921.28M 874.89M 32.87M -
Property plant equipment - 31.33M 38.79M 6.87M 5.33M
Total current assets 231.26M 357.14M 511.90M 97.33M 109.25M
Long term investments - - - - -
Net tangible assets - 325.36M 447.69M 5.00M -212.27800M
Short term investments 0.00000M 75.25M - - -
Net receivables 13.42M 14.69M 11.94M 5.75M 1.98M
Long term debt - - - 53.89M -
Inventory 73.02M 59.97M 36.24M 25.80M 9.44M
Accounts payable 5.09M 7.21M 5.80M 16.40M 5.17M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.00000M - -571.96500M - -
Additional paid in capital - - - - -
Common stock total equity - 0.02M 0.02M 0.00261M -
Preferred stock total equity - - - - -
Retained earnings total equity - -595.93800M -427.21500M -132.20477M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 21.70M 7.54M 21.27M 42.99M -
Deferred long term asset charges - - - - -
Non current assets total 73.01M 60.43M 60.06M 49.86M -
Capital lease obligations 25.03M 29.97M 29.08M 0.00000M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -93.77900M -1.99300M -1.99300M -1.99300M -1.99300M
Change to liabilities 4.38M -3.20700M 18.62M 6.05M 2.42M
Total cashflows from investing activities -93.77900M -9.87000M -2.37600M -4.46800M -1.09800M
Net borrowings - -4.36600M 54.37M 54.37M 54.37M
Total cash from financing activities 2.88M 565.69M 54.28M 0.32M 247.84M
Change to operating activities -5.30600M -30.43000M 57.27M -43.20300M -15.72300M
Net income -168.72300M -32.40900M -162.74500M -99.69700M -50.76500M
Change in cash -260.01300M 366.63M -29.79600M -124.57600M 177.16M
Begin period cash flow 426.84M 60.21M 90.00M 214.58M -
End period cash flow 166.83M 426.84M 60.21M 90.00M 214.58M
Total cash from operating activities -169.11500M -189.18700M -81.70000M -120.43200M -69.58100M
Issuance of capital stock 0.00000M 548.40M - 0.00000M -
Depreciation 5.93M 2.09M 1.32M 0.76M 0.39M
Other cashflows from investing activities 0.06M - -451.61233M -451.61233M -451.61233M
Dividends paid - - - - -
Change to inventory -24.51000M -11.28500M -23.48700M -1.39000M -10.90900M
Change to account receivables -3.06300M -6.12700M -4.37700M -1.19500M -0.75600M
Sale purchase of stock 2.98M 21.71M -0.65700M - -
Other cashflows from financing activities -0.10100M 21.66M 54.94M -4.46800M -2.81200M
Change to netincome 23.07M -107.81900M 31.70M 18.25M 5.76M
Capital expenditures 18.30M 7.88M 2.38M 4.47M 1.10M
Change receivables -3.06300M -6.12700M - - -
Cash flows other operating -6.20700M -32.15200M - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes -260.01300M 366.63M - - -
Change in working capital -29.39700M -51.04900M 48.03M -39.74200M -
Stock based compensation 42.53M 47.80M 11.00M 6.04M -
Other non cash items -19.46100M 2.29M 3.01M 12.21M -
Free cash flow -187.41700M -197.06400M -84.07600M -124.90000M -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BFLY
Butterfly Network Inc
0.07 2.83% 2.37 - - 9.22 3.82 8.19 -9.5686
ABT
Abbott Laboratories
0.24 0.18% 135.86 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation
3.15 0.83% 380.45 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC
1.26 1.44% 88.53 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp
2.30 2.31% 102.04 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

Profile

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Butterfly Network Inc

1600 District Avenue, Burlington, MA, United States, 01803

Key Executives

Name Title Year Born
Dr. Jonathan M. Rothberg Ph.D. Founder, Interim CEO & Chairman 1964
Dr. Andrei G. Stoica Ph.D. Chief Technology Officer 1973
Mr. Darius Shahida Chief Strategy Officer & Chief Bus. Devel. Officer 1992
Dr. Todd M. Fruchterman M.D., Ph.D. Exec. Officer 1970
Ms. Heather C. Getz CPA, M.B.A. Exec. VP & CFO 1975
Mr. David H. Ramsey Chief Information Officer 1970
Mr. Larry Weiss Chief Legal Officer & Corp. Sec. NA
Ms. Tamara Dillon Chief People Officer NA
Dr. John Martin F.A.C.S., M.B.A., M.D. Chief Medical Officer 1959
Mr. Troy Quander Sr. VP of Regulatory & Quality 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.